Home > Official notices > Statutory committee inquiries  |  Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7299 p625
15 May 2004


Statutory committee inquiries

The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.45am on Monday 17 May, Tuesday 18 May and Wednesday 19 May to hear the following inquiries:

Monday 17 May
1. The committee will deliver its determination in an inquiry adjourned from 8 April 2004 into a complaint by the Council of the Society against a superintendent pharmacist, a company and two pharmacists employed by the company, which includes allegations that the presence, at the company’s two registered pharmacy premises, of large amounts of segregated and inadequately segregated out-of-date medicines, the presence of large amounts of medicines of uncertain provenance (which were improperly labelled and where the date of expiry and/or batch number were not present, some of the medicines having been deblistered and/or repackaged) may amount to misconduct.

2. A resumed inquiry into a complaint by the Council of the Society against a pharmacist which includes allegations that a dispensing error and the pharmacist’s failure to contact the prescriber after being alerted to the error may amount to misconduct.

3. The committee will continue an inquiry adjourned from 19 November 2003 into a complaint by the Council of the Society against a pharmacist proprietor and a locum pharmacist employed by him, which includes allegations that the failure by both pharmacists to be truthful when interviewed by the Society’s inspectors and their obstruction of an investigation into a complaint received by the Society regarding an extemporaneously prepared product at the pharmacy may amount to misconduct.

Tuesday 18 May
4. An inquiry into a complaint by the Council of the Society against a pharmacist which alleges that the supply of prescription only medicines in the absence of a pharmacist, the failure to ensure that there was a pharmacist in personal control and the failure to correct misinformation given to a Society inspector may amount to misconduct.

5. The committee will continue an inquiry adjourned from 10 December 2003 into a complaint by the Council of the Society against a pharmacist, which includes allegations that the pharmacist’s failure to ensure that professional indemnity insurance cover was in place from about July 2002 until 12 December 2002 and failure to provide documentary evidence that professional indemnity insurance was in place prior to July 2002 may amount to misconduct.

Wednesday 19 May
6. A resumed inquiry into the case of a pharmacist convicted of driving with an alcohol level which exceeded the prescribed limit.

7. An inquiry into a complaint by the Council of the Society against a pharmacist, which alleges that the operation of a repeat medication service that failed to comply with the service specifications set out in the Society’s Code of Ethics and Standards, a failure to maintain patient medication records in accordance with the Society’s Code of Ethics and Standards and submitting to the Prescription Pricing Authority inaccurately endorsed prescriptions, may amount to misconduct.

8. An inquiry into a complaint by the Council of the Society against a pharmacist, which includes allegations that several dispensing errors, the erroneous endorsing of prescriptions and the inclusion in Nomad trays of drugs that had not been prescribed, may amount to misconduct.

Mary Timms
Acting Secretary to the Statutory Committee

Back to Top


©The Pharmaceutical Journal